Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01625572
Other study ID # TAPPro
Secondary ID
Status Completed
Phase N/A
First received June 19, 2012
Last updated July 28, 2016
Start date July 2012
Est. completion date December 2015

Study information

Verified date July 2016
Source Charite University, Berlin, Germany
Contact n/a
Is FDA regulated No
Health authority Germany: Ethics Commission
Study type Interventional

Clinical Trial Summary

The purpose of this study is to compare the quality of a transversus abdominis plane blockade with an intravenous pain therapy with opioids. Due to the relatively low side effect profile and comparably few contraindications, this method offers a good option, to be a standard procedure or better alternative in the treatment of pain in surgery of the prostate.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date December 2015
Est. primary completion date July 2015
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients at the age of 18 and above, who need an open prostatectomy

- written consent exists

Exclusion Criteria:

- American Society of Anaesthesiologists (ASA) classification > III

- Allergy to local anaesthesia

- Contraindications to one of the applied methods

- previous surgery on the abdominal wall

- chronic pain patients

- Myasthenia gravis

- alcohol dependence

- increased intraocular pressure

- lacking willingness to save and hand out data within the study

- Participation in another trial according to the German Drug Law

- accommodation in an institute due to an official or judicial order

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Transversus abdominis plane blockade
Bilateral one time injection of local anaesthetic in the space between the transversus abdominis muscle and obliquus internus muscle preoperatively. Follow up for three days.
Morphine-patient-controlled-analgesia-device
Morphine-patient-controlled-analgesia-device for three days: 1mg/ml, Dosage 2mg bolus injection on demand every 10 minutes possible.

Locations

Country Name City State
Germany Department of Anaesthesiology and Intensive Care Medicine Campus Charitè Mitte, Charite Universitätsmedizin Berlin Berlin

Sponsors (1)

Lead Sponsor Collaborator
Charite University, Berlin, Germany

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain in rest in the op-area Pain in rest in the op-area during the first 3 days 3 days No
Secondary Opioid consumption opioidconsumption during the first 3 days 3 days No
Secondary Pain in motion in the op-area Pain in the op-area in motion during the first three days 3 days No
Secondary Pain outside the op-area Pain outside the op-area during the first three days 3 days No
Secondary Contentment with the pain therapy at all Contentment with the pain therapy at all for the first three days 3 days No
Secondary Frequency of postoperative vomiting and nausea Frequency of postoperative vomiting and nausea during the first three days 3 days No
Secondary Incidence of pruritus Incidence of pruritus during the first three days 3 days No
Secondary Tenesmuses of the bladder Tenesmus of the bladder during the first three days 3 days No
Secondary Contentment of the Patient at all Contentment of the patient at all during the first three days 3 days No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care